248 related articles for article (PubMed ID: 15751094)
1. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial.
Michel BA; Stucki G; Frey D; De Vathaire F; Vignon E; Bruehlmann P; Uebelhart D
Arthritis Rheum; 2005 Mar; 52(3):779-86. PubMed ID: 15751094
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial.
Kahan A; Uebelhart D; De Vathaire F; Delmas PD; Reginster JY
Arthritis Rheum; 2009 Feb; 60(2):524-33. PubMed ID: 19180484
[TBL] [Abstract][Full Text] [Related]
3. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
[TBL] [Abstract][Full Text] [Related]
4. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.
Uebelhart D; Malaise M; Marcolongo R; de Vathaire F; Piperno M; Mailleux E; Fioravanti A; Matoso L; Vignon E
Osteoarthritis Cartilage; 2004 Apr; 12(4):269-76. PubMed ID: 15023378
[TBL] [Abstract][Full Text] [Related]
5. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens.
Fransen M; Agaliotis M; Nairn L; Votrubec M; Bridgett L; Su S; Jan S; March L; Edmonds J; Norton R; Woodward M; Day R;
Ann Rheum Dis; 2015 May; 74(5):851-8. PubMed ID: 24395557
[TBL] [Abstract][Full Text] [Related]
6. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial.
Sawitzke AD; Shi H; Finco MF; Dunlop DD; Bingham CO; Harris CL; Singer NG; Bradley JD; Silver D; Jackson CG; Lane NE; Oddis CV; Wolfe F; Lisse J; Furst DE; Reda DJ; Moskowitz RW; Williams HJ; Clegg DO
Arthritis Rheum; 2008 Oct; 58(10):3183-91. PubMed ID: 18821708
[TBL] [Abstract][Full Text] [Related]
7. Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study.
Pelletier JP; Raynauld JP; Beaulieu AD; Bessette L; Morin F; de Brum-Fernandes AJ; Delorme P; Dorais M; Paiement P; Abram F; Martel-Pelletier J
Arthritis Res Ther; 2016 Nov; 18(1):256. PubMed ID: 27809891
[TBL] [Abstract][Full Text] [Related]
8. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort.
Martel-Pelletier J; Roubille C; Abram F; Hochberg MC; Dorais M; Delorme P; Raynauld JP; Pelletier JP
Ann Rheum Dis; 2015 Mar; 74(3):547-56. PubMed ID: 24336337
[TBL] [Abstract][Full Text] [Related]
9. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate.
Bruyere O; Honore A; Ethgen O; Rovati LC; Giacovelli G; Henrotin YE; Seidel L; Reginster JY
Osteoarthritis Cartilage; 2003 Jan; 11(1):1-5. PubMed ID: 12505481
[TBL] [Abstract][Full Text] [Related]
10. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial.
Brandt KD; Mazzuca SA; Katz BP; Lane KA; Buckwalter KA; Yocum DE; Wolfe F; Schnitzer TJ; Moreland LW; Manzi S; Bradley JD; Sharma L; Oddis CV; Hugenberg ST; Heck LW
Arthritis Rheum; 2005 Jul; 52(7):2015-25. PubMed ID: 15986343
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, double-blind, placebo-controlled clinical trial at a single center.
Gabay C; Medinger-Sadowski C; Gascon D; Kolo F; Finckh A
Arthritis Rheum; 2011 Nov; 63(11):3383-91. PubMed ID: 21898340
[TBL] [Abstract][Full Text] [Related]
12. Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study.
Martel-Pelletier J; Raynauld JP; Mineau F; Abram F; Paiement P; Delorme P; Pelletier JP
Arthritis Res Ther; 2017 Jul; 19(1):169. PubMed ID: 28728606
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial.
Raynauld JP; Buckland-Wright C; Ward R; Choquette D; Haraoui B; Martel-Pelletier J; Uthman I; Khy V; Tremblay JL; Bertrand C; Pelletier JP
Arthritis Rheum; 2003 Feb; 48(2):370-7. PubMed ID: 12571845
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study.
Uebelhart D; Thonar EJ; Delmas PD; Chantraine A; Vignon E
Osteoarthritis Cartilage; 1998 May; 6 Suppl A():39-46. PubMed ID: 9743819
[TBL] [Abstract][Full Text] [Related]
15. Does statin use have a disease modifying effect in symptomatic knee osteoarthritis? Study protocol for a randomised controlled trial.
Wang Y; Tonkin A; Jones G; Hill C; Ding C; Wluka AE; Forbes A; Cicuttini FM
Trials; 2015 Dec; 16():584. PubMed ID: 26700937
[TBL] [Abstract][Full Text] [Related]
16. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study.
Mazieres B; Combe B; Phan Van A; Tondut J; Grynfeltt M
J Rheumatol; 2001 Jan; 28(1):173-81. PubMed ID: 11196521
[TBL] [Abstract][Full Text] [Related]
17. The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate .
Hochberg MC; Zhan M; Langenberg P
Curr Med Res Opin; 2008 Nov; 24(11):3029-35. PubMed ID: 18826751
[TBL] [Abstract][Full Text] [Related]
18. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173].
Spector TD; Conaghan PG; Buckland-Wright JC; Garnero P; Cline GA; Beary JF; Valent DJ; Meyer JM
Arthritis Res Ther; 2005; 7(3):R625-33. PubMed ID: 15899049
[TBL] [Abstract][Full Text] [Related]
19. Equivalence of a single dose (1200 mg) compared to a three-time a day dose (400 mg) of chondroitin 4&6 sulfate in patients with knee osteoarthritis. Results of a randomized double blind placebo controlled study.
Zegels B; Crozes P; Uebelhart D; Bruyère O; Reginster JY
Osteoarthritis Cartilage; 2013 Jan; 21(1):22-7. PubMed ID: 23059756
[TBL] [Abstract][Full Text] [Related]
20. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
Lohmander LS; Hellot S; Dreher D; Krantz EF; Kruger DS; Guermazi A; Eckstein F
Arthritis Rheumatol; 2014 Jul; 66(7):1820-31. PubMed ID: 24740822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
